Playback speed
10 seconds
Anti-PD-1 / Anti-PD-L1 as Standard 2nd Line Treatment Improved OS in Pretreated Advanced NSCLC
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Basak Oyan Uluc
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Basak Oyan Uluc
113 views
November 12, 2019
Login to view comments.
Click here to Login